{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "PRE", "exchange": "NMS", "regularMarketChangePercent": 4.2592597, "regularMarketPrice": 0.2815, "firstTradeDateMilliseconds": 1591363800000, "priceHint": 4, "earningsTimestamp": 1683835501, "earningsTimestampStart": 1690973940, "earningsTimestampEnd": 1691409600, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -3.1, "epsForward": -0.88, "epsCurrentYear": -1.09, "priceEpsCurrentYear": -0.25825688, "sharesOutstanding": 39201000, "bookValue": 1.553, "fiftyDayAverage": 0.33882, "fiftyDayAverageChange": -0.05732, "fiftyDayAverageChangePercent": -0.16917537, "twoHundredDayAverage": 0.86046, "twoHundredDayAverageChange": -0.57895994, "twoHundredDayAverageChangePercent": -0.67284936, "marketCap": 11566385, "forwardPE": -0.3198864, "priceToBook": 0.18126209, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-06-05", "averageAnalystRating": "3.7 - Underperform", "tradeable": false, "cryptoTradeable": false, "shortName": "Applied Molecular Transport Inc", "longName": "Applied Molecular Transport Inc.", "messageBoardId": "finmb_291566008", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": 0.011500001, "regularMarketTime": 1684180805, "regularMarketDayHigh": 0.2815, "regularMarketDayRange": "0.256 - 0.2815", "regularMarketDayLow": 0.256, "regularMarketVolume": 97163, "regularMarketPreviousClose": 0.27, "bid": 0.0, "ask": 0.0, "bidSize": 31, "askSize": 18, "fullExchangeName": "NasdaqGS", "financialCurrency": "USD", "regularMarketOpen": 0.26, "averageDailyVolume3Month": 196503, "averageDailyVolume10Day": 137820, "fiftyTwoWeekLowChange": 0.070500016, "fiftyTwoWeekLowChangePercent": 0.3341233, "fiftyTwoWeekRange": "0.211 - 4.32", "fiftyTwoWeekHighChange": -4.0385003, "fiftyTwoWeekHighChangePercent": -0.934838, "fiftyTwoWeekLow": 0.211, "fiftyTwoWeekHigh": 4.32, "displayName": "Applied Molecular Transport", "symbol": "AMTI"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "450 East Jamie Court", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 392 0420", "website": "https://www.appliedmt.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trials to treat patients with chronic pouchitis, as well as is in Phase II development to treat patients with rheumatoid arthritis. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral and respiratory biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 79, "companyOfficers": [{"maxAge": 1, "name": "Mr. Shawn M. Cross", "age": 54, "title": "CEO & Chairman", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 679785, "fmt": "679.78k", "longFmt": "679,785"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Tahir  Mahmood Ph.D.", "age": 47, "title": "Co-Founder & Director", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": {"raw": 870290, "fmt": "870.29k", "longFmt": "870,290"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Brandon  Hants", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Andrew H. Chang", "title": "Head of Investor Relations & Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Earl M. Douglas", "age": 59, "title": "Exec. VP & Gen. Counsel", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 6, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}